TY - JOUR
T1 - Striking Difference in Antiproliferative Activity of Ruthenium- and Osmium-Nitrosyl Complexes with Azole Heterocycles
AU - Büchel, Gabriel
AU - Gavriluta, Anatolie
AU - Novak, Maria
AU - Meier, Samuel Matthias
AU - Jakupec, Michael
AU - Cuzan, Olesea
AU - Turta, Constantin
AU - Tommasino, J.B.
AU - Jeanneau, Erwann
AU - Novitchi, Ghenadie
AU - Luneau, Dominique
AU - Arion, Vladimir
N1 - Accession Number: WOS:000320015700008
PY - 2013
Y1 - 2013
N2 - Ruthenium nitrosyl complexes of the general formulas (cation)(+)[cis-RuCL4(NO)(Hazole)](-), where (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (Hind) (1c), (cation)(+) = (H(2)pz)(+), Hazole = 1H-pyrazole (Hpz) (2c), (cation)(+) = (H(2)bzim)(+), Hazole = 1H-benzimidazole (Hbzim) (3c), (cation)(+) = (H(2)im)(+), Hazole = 1H-imidazole (Him) (4c) and (cation)(+)[trans-RuCl4(NO)(Hazole)](-), where (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (1t), (cation)(+) = (H(2)pz)(+), Hazole = 1H-pyrazole (2t), as well as osmium analogues of the general formulas (cation)(+)[cis-OsCl4(NO)(Hazole)](-), where (cation)(+) = (n-Bu4N)(+), Hazole = 1H-indazole (5c), 1H-pyrazole (6c), 1H-benzimidazole (7c), 1H-imidazole (8c), (cation)(+) = Na+; Hazole = 1H-indazole (9c), 1H-benzimidazole (10c), (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (11c), (cation)(+) = H(2)pz(+), Hazole = 1H-pyrazole (12c), (cation)(+) = (H(2)im)(+), Hazole = 1H-imidazole (13c), and (cation)(+)[trans-OsCl4(NO)-(Hazole)](-), where (cation)(+) = n-Bu4N+, Hazole = 1H-indazole (5t), 1H-pyrazole (6t), (cation)(+) = Na+, Hazole = 1H-indazole (9t), (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (11t), (cation)(+) = (H(2)pz)(+), Hazole = 1H-pyrazole (12t), have been synthesized. The compounds have been comprehensively characterized by elemental analysis, ESI mass spectrometry, spectroscopic techniques (IR, UV-vis, ID and 2D NMR) and X-ray crystallography (1c center dot CHCl3, 1t center dot CHCl3, 2t, 3c, 6c, 6t, 8c). The antiproliferative activity of water-soluble compounds (1c, it, 3c, 4c and 9c, 9t, 10c, 11c, lit, 12c, 12t, 13c) in the human cancer cell lines A549 (nonsmall cell lung carcinoma), CH1 (ovarian carcinoma), and SW480 (colon adenocarcinoma) has been assayed. The effects of metal (Ru vs Os), cis/trans isomerism, and azole heterocycle identity on cytotoxic potency and cell line selectivity have been elucidated. Ruthenium complexes (1c, 1t, 3c, and 4c) yielded IC50 values in the low micromolar concentration range. In contrast to most pairs of analogous ruthenium and osmium complexes known, they turned out to be considerably more cytotoxic than chemically related osmium complexes (9c, 9t, 10c, 11c, 11t, 12c, 12t, 13c). The IC50 values of Os/Ru homologs differ by factors (Os/Ru) of up to similar to 110 and similar to 410 in CH1 and SW480 cells, respectively. ESI-MS studies revealed that ascorbic acid may activate the ruthenium complexes leading to hydrolysis of one M-Cl bond, whereas the osmium analogues tend to be inert The interaction with myoglobin suggests nonselective adduct formation; i.e., proteins may act as carriers for these compounds.
AB - Ruthenium nitrosyl complexes of the general formulas (cation)(+)[cis-RuCL4(NO)(Hazole)](-), where (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (Hind) (1c), (cation)(+) = (H(2)pz)(+), Hazole = 1H-pyrazole (Hpz) (2c), (cation)(+) = (H(2)bzim)(+), Hazole = 1H-benzimidazole (Hbzim) (3c), (cation)(+) = (H(2)im)(+), Hazole = 1H-imidazole (Him) (4c) and (cation)(+)[trans-RuCl4(NO)(Hazole)](-), where (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (1t), (cation)(+) = (H(2)pz)(+), Hazole = 1H-pyrazole (2t), as well as osmium analogues of the general formulas (cation)(+)[cis-OsCl4(NO)(Hazole)](-), where (cation)(+) = (n-Bu4N)(+), Hazole = 1H-indazole (5c), 1H-pyrazole (6c), 1H-benzimidazole (7c), 1H-imidazole (8c), (cation)(+) = Na+; Hazole = 1H-indazole (9c), 1H-benzimidazole (10c), (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (11c), (cation)(+) = H(2)pz(+), Hazole = 1H-pyrazole (12c), (cation)(+) = (H(2)im)(+), Hazole = 1H-imidazole (13c), and (cation)(+)[trans-OsCl4(NO)-(Hazole)](-), where (cation)(+) = n-Bu4N+, Hazole = 1H-indazole (5t), 1H-pyrazole (6t), (cation)(+) = Na+, Hazole = 1H-indazole (9t), (cation)(+) = (H(2)ind)(+), Hazole = 1H-indazole (11t), (cation)(+) = (H(2)pz)(+), Hazole = 1H-pyrazole (12t), have been synthesized. The compounds have been comprehensively characterized by elemental analysis, ESI mass spectrometry, spectroscopic techniques (IR, UV-vis, ID and 2D NMR) and X-ray crystallography (1c center dot CHCl3, 1t center dot CHCl3, 2t, 3c, 6c, 6t, 8c). The antiproliferative activity of water-soluble compounds (1c, it, 3c, 4c and 9c, 9t, 10c, 11c, lit, 12c, 12t, 13c) in the human cancer cell lines A549 (nonsmall cell lung carcinoma), CH1 (ovarian carcinoma), and SW480 (colon adenocarcinoma) has been assayed. The effects of metal (Ru vs Os), cis/trans isomerism, and azole heterocycle identity on cytotoxic potency and cell line selectivity have been elucidated. Ruthenium complexes (1c, 1t, 3c, and 4c) yielded IC50 values in the low micromolar concentration range. In contrast to most pairs of analogous ruthenium and osmium complexes known, they turned out to be considerably more cytotoxic than chemically related osmium complexes (9c, 9t, 10c, 11c, 11t, 12c, 12t, 13c). The IC50 values of Os/Ru homologs differ by factors (Os/Ru) of up to similar to 110 and similar to 410 in CH1 and SW480 cells, respectively. ESI-MS studies revealed that ascorbic acid may activate the ruthenium complexes leading to hydrolysis of one M-Cl bond, whereas the osmium analogues tend to be inert The interaction with myoglobin suggests nonselective adduct formation; i.e., proteins may act as carriers for these compounds.
U2 - 10.1021/ic400555k
DO - 10.1021/ic400555k
M3 - Article
SN - 0020-1669
VL - 52
SP - 6273
EP - 6285
JO - Inorganic Chemistry
JF - Inorganic Chemistry
IS - 11
ER -